HLA-G: A New Immune Checkpoint in Cancer?
Human leukocyte antigen G (HLA-G), known as a central protein in providing immune tolerance to the fetus in pregnant women, is also studied for a possible role in tumor development. Many studies have claimed HLA-G as a new immune checkpoint in cancer. Therefore, HLA-G and its receptors might be targ...
Main Authors: | Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, Davide Bedognetti, Peter J. K. Kuppen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/12/4528 |
Similar Items
-
HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
by: Fabio Morandi, et al.
Published: (2022-03-01) -
The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?
by: Jiji V. D. Attia, et al.
Published: (2020-11-01) -
HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells
by: Bianca Altvater, et al.
Published: (2021-06-01) -
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
by: Siyuan Wang, et al.
Published: (2024-02-01) -
A Critical Assessment of the Association between HLA-G Expression by Carcinomas and Clinical Outcome
by: Ricky B. van de Water, et al.
Published: (2021-07-01)